Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-02-28 00:00:00 ET · period of report 2022-02-24 · accession 0000899243-22-008123 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-02-28 | 2022-02-25 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | S - Sale | $230.95 | -325 | 50.3K | -0.6% | -$75.1K |
| 2022-02-28 | 2022-02-24 | VRTX | Tatsis Ourania | EVP, Chief Reg, Quality Off | F - Tax | $227.86 | -2,590 | 50.5K | -5% | -$590.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-25 | S | D | 77 | $230.26 | 50,409 | D | — | — | (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $230.26 (range $229.50 to $230.48). |
| 2 | Common | Common Stock | 2022-02-25 | S | D | 87 | $231.81 | 50,207 | D | — | — | (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $231.81 (range $231.52 to $232.31). |
| 3 | Common | Common Stock | 2022-02-25 | S | D | 18 | $232.80 | 50,189 | D | — | — | (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $232.80 (range $232.59 to $232.92). |
| 4 | Common | Common Stock | 2022-02-25 | S | D | 28 | $228.88 | 50,486 | D | — | — | (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F2) Open market sales reported on this line occurred at a weighted average price of $228.88 (range $228.39 to $229.36). |
| 5 | Common | Common Stock | 2022-02-24 | F | D | 2,590 | $227.86 | 50,514 | D | — | — | |
| 6 | Common | Common Stock | 2022-02-25 | S | D | 115 | $230.97 | 50,294 | D | — | — | (F3) Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $230.97 (range $230.50 to $231.47). |